Literature DB >> 10670110

[The influence of taurolidine on physiological and pathological blood coagulation and implications for its use].

J Reinmüller1.   

Abstract

Taurolidine is an anti-infective agent with an unusually broad spectrum of effectivity against gram-positive and gram-negative bacteria, anaerobic organisms, and fungi. The effective principle is explained by the decomposition of the substance and the transfer of methylol groups to specific molecular structures of the cell walls of microbes. The acceptors are amino groups of the amino sugars and the lysine residues of glycoproteids. More recent investigations have shown that the effect of taurolidine is not limited to microorganisms, but can be detected in cells of the macrorganism as well. Here the influence of taurolidine on different blood clotting factors is described. The results can be explained by a transfer of methylol groups to residues of arginine and histidine in the active region, in analogy to the transfer to lysine residues in microorganisms. It is therefore to be expected that taurolidine will influence other vital systems of the macroorganism, dependently of concentration, as long as their biological function is connected to residues of arginine or histidine. Examples are the complement system and the fibrinolysis system. The implications of these observations have to do with new indications in connection with clotting phenomena in extracorporal circulatory systems or with thrombolysis, as well as with known indications in cases of shock and sepsis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10670110

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  4 in total

1.  Comparative in vitro efficacies of various catheter lock solutions.

Authors:  Robert J Sherertz; Michael S Boger; Casey A Collins; Lori Mason; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

2.  Antimicrobial activity of a novel catheter lock solution.

Authors:  Chirag B Shah; Marc W Mittelman; J W Costerton; Stephen Parenteau; Michael Pelak; Richard Arsenault; Leonard A Mermel
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition.

Authors:  Y Wouters; M Theilla; P Singer; S Tribler; P B Jeppesen; L Pironi; L Vinter-Jensen; H H Rasmussen; F Rahman; G J A Wanten
Journal:  Aliment Pharmacol Ther       Date:  2018-07-05       Impact factor: 8.171

4.  The best solution down the line: an observational study on taurolidine- versus citrate-based lock solutions for central venous catheters in hemodialysis patients.

Authors:  Sonja van Roeden; Mathijs van Oevelen; Alferso C Abrahams; Friedo W Dekker; Joris I Rotmans; Sabine C A Meijvis
Journal:  BMC Nephrol       Date:  2021-09-13       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.